Super-Enhancers in the Control of Cell Identity and Disease

Hnisz, Denes, Abraham, Brian J., Lee, Tong Ihn, Lau, Ashley, Saint-André, Violaine, Sigova, Alla A., Hoke, Heather A., Young, Richard A.·2013·Cell
DOI 10.1016/j.cell.2013.09.053

Cited by (1,018)

Items 201–300 of 1,018

  1. Liquid–liquid phase separation in tumor biology
    Xuhui Tong, Rong Tang, Jin Xu, Wei Wang, Yingjun Zhao, Xianjun Yu, Si Shi · 2022 · Signal Transduction and Targeted Therapy
  2. Convergent Transcription at Intragenic Super-Enhancers Targets AID-Initiated Genomic Instability
    Fei‐Long Meng, Zhou Du, Alexander Joel Federation, Jiazhi Hu, Qiao Wang, Kyong-Rim Kieffer-Kwon, Robin M. Meyers, Corina Amor, Caitlyn R. Wasserman, Donna S Neuberg et al. · 2014 · Cell
  3. Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients
    De‐Chen Lin, Ming‐Rong Wang, Harold Phillip Koeffler · 2017 · Gastroenterology
  4. Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate
    Preston R. Arnold, Andrew D. Wells, X.C. Li · 2020 · Frontiers in Cell and Developmental Biology
  5. The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes
    Tasnim H. Beacon, Geneviève P. Delcuve, Camila L. Lopez, Gino Nardocci, Igor Kovalchuk, André J. van Wijnen, James Davie · 2021 · Clinical Epigenetics
  6. Identification of six new susceptibility loci for invasive epithelial ovarian cancer
    EMBRACE, Kuchenbaecker, Karoline B, GEMO Study Collaborators, Breast Cancer Family Registry, HEBON, KConFab Investigators, Australian Cancer Study (Ovarian Cancer Investigators), Australian Ovarian Cancer Study Group, the Consortium of Investigators of Modifiers of BRCA1 and BRCA2, Ramus, Susan J et al. · 2015 · Nature Genetics
  7. Bromodomain biology and drug discovery
    Nilesh Zaware, Ming‐Ming Zhou · 2019 · Nature Structural & Molecular Biology
  8. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition
    Wang, Chaochen, Lee, Ji-Eun, Lai, Binbin, Macfarlan, Todd S., Xu, Shiliyang, Zhuang, Lenan, Liu, Chengyu, Peng, Weiqun, Ge, Kai · 2016 · Proceedings of the National Academy of Sciences
  9. Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy
    Kerstin Hartmann, Mascha Koenen, Sebastian Schauer, Stephanie Wittig-Blaich, Mubashir Ahmad, Ulrike Baschant, Jan Peter Tuckermann · 2016 · Physiological Reviews
  10. Functional inference of gene regulation using single-cell multi-omics
    Kartha, Vinay K., Duarte, Fabiana M., Hu, Yan, Ma, Sai, Chew, Jennifer G., Lareau, Caleb A., Earl, Andrew, Burkett, Zach D., Kohlway, Andrew S., Lebofsky, Ronald et al. · 2022 · Cell Genomics
  11. Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis
    Jialiang Huang, Xin Liu, Dan Li, Zhen Shao, Hui Cao, Yuannyu Zhang, Eirini Trompouki, Teresa V. Bowman, Leonard Ira Zon, Guo‐Cheng Yuan et al. · 2016 · Developmental Cell
  12. Common stemness regulators of embryonic and cancer stem cells
    Christiana Hadjimichael · 2015 · World Journal of Stem Cells
  13. 50+ years of eukaryotic transcription: an expanding universe of factors and mechanisms
    Robert G. Roeder · 2019 · Nature Structural & Molecular Biology
  14. MNase titration reveals differences between nucleosome occupancy and chromatin accessibility
    Jakub Mieczkowski, April Cook, Sarah Bowman, Britta Mueller, Burak H. Alver, Sharmistha Kundu, Aimée M. Deaton, Jennifer A. Urban, Erica Larschan, Peter J. Park et al. · 2016 · Nature Communications
  15. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma
    Jiyuan Zhang, Sofija Vlasevska, Victoria A. Wells, Sarah E. Nataraj, Antony B. Holmes, Romain Duval, Stefanie N. Meyer, Tongwei Mo, Katia Basso, Paul K. Brindle et al. · 2017 · Cancer Discovery
  16. RETRACTED: Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma
    Jian-Jun Xie, Yan-Yi Jiang, Yuan Ying Jiang, Chunquan Li, Mei Chee Lim, Ömer An, Anand Mayakonda, Ling‐Wen Ding, Lin Long, Chun Sun et al. · 2018 · Gastroenterology · Retracted
  17. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
    Bettina Wingelhofer, Heidi Anne Neubauer, Peter Valent, Xiaonan Han, Stefan N. Constantinescu, Patrick Thomas Gunning, Mathias M. Müller, Richard Moriggl · 2018 · Leukemia
  18. Systems and Synthetic microRNA Biology: From Biogenesis to Disease Pathogenesis
    Hironori Matsuyama, Hiroshi I. Suzuki · 2019 · International Journal of Molecular Sciences
  19. Dissecting super-enhancer hierarchy based on chromatin interactions
    Huang, Jialiang, Li, Kailong, Cai, Wenqing, Liu, Xin, Zhang, Yuannyu, Orkin, Stuart H., Xu, Jian, Yuan, Guo-Cheng · 2018 · Nature Communications
  20. Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1
    Eleni M. Tomazou, Nathan C. Sheffield, Christian Schmidl, Michael K. Schuster, Andreas Schönegger, Paul Datlinger, Stefan Kubicek, Christoph Bock, Heinrich Kovar · 2015 · Cell Reports
  21. Whole-genome sequencing of a sporadic primary immunodeficiency cohort
    James E. D. Thaventhiran, Hana Lango Allen, Oliver S. Burren, William M. Rae, Daniel J. Greene, Emily Staples, Zinan Zhang, James H. R. Farmery, Ilenia Simeoni, Elizabeth Rivers et al. · 2020 · Nature
  22. Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer
    Narsis Attar, Siavash K. Kurdistani · 2016 · Cold Spring Harbor Perspectives in Medicine
  23. Enhancer variants: evaluating functions in common disease
    Corradin, Olivia, Scacheri, Peter C · 2014 · Genome Medicine
  24. Nuclear compartmentalization as a mechanism of quantitative control of gene expression
    Prashant Bhat, Drew D. Honson, Mitchell Guttman · 2021 · Nature Reviews Molecular Cell Biology
  25. Enhancer redundancy in development and disease
    Evgeny Z. Kvon, Rachel Waymack, Mario Gad, Zeba Wunderlich · 2021 · Nature Reviews Genetics
  26. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review)
    Masaru Katoh · 2018 · International Journal of Molecular Medicine
  27. Identification of Novel Genetic Markers of Breast Cancer Survival
    Qi Jin Guo, Marjanka K. Schmidt, Peter L. Kraft, Sander Canisius, Constance Chen, Sofia Khan, Jonathan P. Tyrer, Manjeet K. Bolla, Qin Wang, Joe Dennis et al. · 2015 · JNCI Journal of the National Cancer Institute
  28. A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
    Paola A. Betancur, Brian J. Abraham, Ying Ying Yiu, Stephen B. Willingham, Farnaz Khameneh, Mark A. Zarnegar, Angera H. Kuo, Kelly Marie McKenna, Yoko Kojima, Nicholas James Leeper et al. · 2017 · Nature Communications
  29. Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism
    Jurian Schuijers, John C. Manteiga, Abraham S. Weintraub, Daniel S. Day, Alicia Viridiana Zamudio, Denes Hnisz, Tong Ihn Lee, Richard A. Young · 2018 · Cell Reports
  30. MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification
    Mark W. Zimmerman, Yu Liu, Shuning He, Adam David Durbin, Brian J. Abraham, John B. Easton, Ying Shao, Beisi Xu, Shizhen Zhu, Xiaoling Zhang et al. · 2017 · Cancer Discovery
  31. NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling
    Sudhir Chowdhry, Ciro Zanca, Utkrisht Rajkumar, Tomoyuki Koga, Yarui Diao, Ramya Raviram, Feng Liu, Kristen M. Turner, Huijun Yang, Elizabeth Brunk et al. · 2019 · Nature
  32. Genetic, Epigenetic, and Environmental Contributions to Neural Tube Closure
    Jonathan J. Wilde, Juliette R. Petersen, Lee Ann Niswander · 2014 · Annual Review of Genetics
  33. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
    Rhamy Zeid, Matthew A. Lawlor, Evon Poon, Jaime M. Reyes, Mariateresa Fulciniti, Michael A. Lopez, Thomas G. Scott, Behnam Nabet, Michael A. Erb, Georg E. Winter et al. · 2018 · Nature Genetics
  34. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression
    Yuan Ying Jiang, Yan-Yi Jiang, Jian‐Jun Xie, Anand Mayakonda, Masaharu Hazawa, Li Chen, Jin-Fen Xiao, Chunquan Li, Moli Huang, Ling‐Wen Ding et al. · 2018 · Nature Communications
  35. Evaluating Enhancer Function and Transcription
    Andrew R. Field, Karen Adelman · 2020 · Annual Review of Biochemistry
  36. Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells
    Tahsin Stefan Barakat, Florian Halbritter, Man Zhang, André F. Rendeiro, Elena Perenthaler, Christoph Bock, Ian Chambers · 2018 · Cell stem cell
  37. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia
    Andreas Kloetgen, Palaniraja Thandapani, Panagiotis Ntziachristos, Yohana E. Ghebrechristos, Sofia Nomikou, Charalampos Lazaris, Xufeng Chen, Hai Hu, Sofia Bakogianni, Jingjing Wang et al. · 2020 · Nature Genetics
  38. Reconstruction of enhancer–target networks in 935 samples of human primary cells, tissues and cell lines
    Qin Cao, Christine Anyansi, Xihao Sherlock Hu, Liangliang Xu, Lei Xiong, Wenshu Tang, Myth T.S. Mok, Chao Cheng, Xiaodan Fan, Mark Gerstein et al. · 2017 · Nature Genetics
  39. Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma
    Lindsay M. LaFave, Vinay K. Kartha, Sai Ma, Kevin Meli, Isabella S. Del Priore, Caleb A. Lareau, Santiago Naranjo, Peter M.K. Westcott, Fabiana M. Duarte, Venkat Sankar et al. · 2020 · Cancer Cell
  40. GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture
    Remi Stevelink, Ciarán Campbell, Siwei Chen, Bassel W Abou-Khalil, Oluyomi M. Adesoji, Zaid Afawi, Elisabetta Amadori, Alison Anderson, Joseph Anderson, Danielle Molinari Andrade et al. · 2023 · Nature Genetics
  41. Treg cells in health and autoimmune diseases: New insights from single cell analysis
    Clemens Scheinecker, Lisa Göschl, Michael Markus Bonelli · 2019 · Journal of Autoimmunity
  42. Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
    Gerard L. Brien, David Remillard, Junwei Shi, Matthew L. Hemming, Jonathon Chabon, Kieran J. Wynne, Eugène Dillon, Gerard Cagney, Guido van Mierlo, Marijke P. A. Baltissen et al. · 2018 · eLife
  43. Treg cells in autoimmunity: from identification to Treg-based therapies
    Lisa Göschl, Clemens Scheinecker, Michael Markus Bonelli · 2019 · Seminars in Immunopathology
  44. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
    Stephen C. Mack, Kristian W. Pajtler, Lukas Chávez, Konstantin Okonechnikov, Kelsey C. Bertrand, Xiuxing Wang, Serap Erkek, Alexander Joel Federation, Anne Song, Christine Lee et al. · 2017 · Nature
  45. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
    NBCS Collaborators, Lang Wu, kConFab/AOCS Investigators, Wei Shi, Jirong Long, Xingyi Guo, Kyriaki Michailidou, Jonathan Beesley, Manjeet K. Bolla, Xiao‐Ou Shu et al. · 2018 · Nature Genetics
  46. Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma
    Yan-Yi Jiang, De‐Chen Lin, Anand Mayakonda, Masaharu Hazawa, Ling‐Wen Ding, Wen-Wen Chien, Liang Xu, Ye Chen, Jin‐Fen Xiao, William T. Senapedis et al. · 2016 · Gut
  47. Genetic determinants of co-accessible chromatin regions in activated T cells across humans
    Gate, Rachel E., Cheng, Christine S., Aiden, Aviva P., Siba, Atsede, Tabaka, Marcin, Lituiev, Dmytro, Machol, Ido, Gordon, M. Grace, Subramaniam, Meena, Shamim, Muhammad et al. · 2018 · Nature Genetics
  48. Enhancer Activation Requires trans-Recruitment of a Mega Transcription Factor Complex
    Zhijie Liu, Daria Merkurjev, Feng Yang, Wenbo Li, Soohwan Oh, Meyer J. Friedman, Xiaoyuan Song, Feng Zhang, Qi Ma, Kenneth A. Ohgi et al. · 2014 · Cell
  49. Integrated genomic analyses of de novo pathways underlying atypical meningiomas
    Akdes Serin Harmancı, Mark W. Youngblood, Victoria Elizabeth Clark, Süleyman Coşkun, Octavian Henegariu, Daniel Durán, Zeynep Erson-Omay, Leon D. Kaulen, Tong Ihn Lee, Brian J. Abraham et al. · 2017 · Nature Communications
  50. CoBATCH for High-Throughput Single-Cell Epigenomic Profiling
    Wang, Qianhao, Xiong, Haiqing, Ai, Shanshan, Yu, Xianhong, Liu, Yaxi, Zhang, Jiejie, He, Aibin · 2019 · Molecular Cell
  51. Control of Embryonic Stem Cell Identity by BRD4-Dependent Transcriptional Elongation of Super-Enhancer-Associated Pluripotency Genes
    Di Micco, Raffaella, Fontanals-Cirera, Barbara, Low, Vivien, Ntziachristos, Panagiotis, Yuen, Stephanie K., Lovell, Claudia D., Dolgalev, Igor, Yonekubo, Yoshiya, Zhang, Guangtao, Rusinova, Elena et al. · 2014 · Cell Reports
  52. Assessing sufficiency and necessity of enhancer activities for gene expression and the mechanisms of transcription activation
    Rui R. Catarino, Alexander Stark · 2018 · Genes & Development
  53. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer
    Holger Heyn, Enrique Vidal, Humberto J. Ferreira, Miguel Vizoso, Sergi Sayols, Antonio Gómez, Sebastián Morán, Raquel Boqué-Sastre, Sònia Guil, Anna Martínez‐Cardús et al. · 2016 · Genome biology
  54. Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF
    Kang, Kyuho, Park, Sung Ho, Chen, Janice, Qiao, Yu, Giannopoulou, Eugenia, Berg, Karen, Hanidu, Adedayo, Li, Jun, Nabozny, Gerald, Kang, Keunsoo et al. · 2017 · Immunity
  55. SEdb: a comprehensive human super-enhancer database
    Yong Jiang, Fengcui Qian, Xuefeng Bai, Yuejuan Liu, Qiuyu Wang, Bo Ai, Xiaole Han, Shanshan Shi, Jian Zhang, Xuecang Li et al. · 2018 · Nucleic Acids Research
  56. CDK9: a signaling hub for transcriptional control
    Curtis W. Bacon, Iván D’Orso · 2018 · Transcription
  57. mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence
    Soo Seok Hwang, Jaechul Lim, Zhibin Yu, Philip L. Kong, Esen Sefik, Hao Ying Xu, Christian C. D. Harman, Lark Kyun Kim, Gap Ryol Lee, Huabing Li et al. · 2020 · Science
  58. Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer
    Shaokun Shu, Hua‐Jun Wu, Jennifer Y. Ge, Rhamy Zeid, Isaac S. Harris, Bojana Jovanović, Katherine C. Murphy, Binbin Wang, Xintao Qiu, Jennifer E. Endress et al. · 2020 · Molecular Cell
  59. Architecture of gene regulatory networks controlling flower development in Arabidopsis thaliana
    Dijun Chen, Wenhao Yan, Liang-Yu Fu, Kerstin Kaufmann · 2018 · Nature Communications
  60. CDK7 inhibitors as anticancer drugs
    Georgina P. Sava, Hailing Fan, R. Charles Coombes, Laki Buluwela, Simak Ali · 2020 · Cancer and Metastasis Reviews
  61. CRISPR Reveals a Distal Super-Enhancer Required for Sox2 Expression in Mouse Embryonic Stem Cells
    Li, Yan, Rivera, Chloe M., Ishii, Haruhiko, Jin, Fulai, Selvaraj, Siddarth, Lee, Ah Young, Dixon, Jesse R., Ren, Bing · 2014 · PLoS ONE
  62. HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
    Trang Thi Thu Nguyen, Yiru Zhang, Enyuan Shang, Chang Shu, Consuelo Torrini, Junfei Zhao, Elena Bianchetti, Angeliki Mela, Nelson Humala, Aayushi Mahajan et al. · 2020 · Journal of Clinical Investigation
  63. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
    Siddhartha Kar, Jonathan Beesley, Ali Amin Al Olama, Kyriaki Michailidou, Jonathan P. Tyrer, Zsofia Kote‐Jarai, Kate Lawrenson, Sara Lindström, Susan J. Ramus, Deborah J. Thompson et al. · 2016 · Cancer Discovery
  64. The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains
    Artyom A. Alekseyenko, Erica M. Walsh, Xin Wang, Adlai R. Grayson, Peter T. Hsi, Peter V. Kharchenko, Mitzi I. Kuroda, Christopher Alexander French · 2015 · Genes & Development
  65. Spatially resolved epigenomic profiling of single cells in complex tissues
    Lu, Tian, Ang, Cheen Euong, Zhuang, Xiaowei · 2022 · Cell
  66. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia
    Renée Beekman, Vicente Chapaprieta, Núria Russiñol, Roser Vilarrasa‐Blasi, Núria Verdaguer-Dot, Joost H.A. Martens, Martí Duran‐Ferrer, Marta Kulis, François Serra, Biola M. Javierre et al. · 2018 · Nature Medicine
  67. Dnmt3a and Dnmt3b Associate with Enhancers to Regulate Human Epidermal Stem Cell Homeostasis
    Lorenzo Rinaldi, Debayan Datta, Judit Serrat, Lluís Morey, Guiomar Solanas, Alexandra Avgustinova, Enrique Blanco, J. Pons, David Matallanas, Alex von Kriegsheim et al. · 2016 · Cell stem cell
  68. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes
    Sakthi D. Moorthy, Scott Davidson, Virlana M. Shchuka, Gurdeep Singh, Nakisa Malek-Gilani, Lida Langroudi, Alexandre Martchenko, Vincent So, Neil N. Macpherson, Jennifer A. Mitchell · 2016 · Genome Research
  69. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs
    Nasun Hah, Christopher W. Benner, Ling-Wa Chong, Ruth T. Yu, Michael Downes, Ronald M. Evans · 2015 · Proceedings of the National Academy of Sciences
  70. Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers
    Jian Yan, Shi-An A. Chen, Andrea Local, Tristin Liu, Yunjiang Qiu, Ah Young Lee, Inkyung Jung, Sebastian Preißl, Chloe M. Rivera, Chaochen Wang et al. · 2018 · Cell Research
  71. TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer
    Ken J. Kron, Alexander J. Murison, Stanley Zhou, Vincent Huang, Takafumi N. Yamaguchi, Yu-Jia Shiah, Michael E. Fraser, Theodorus van der Kwast, Paul Christopher Boutros, Robert Glen Bristow et al. · 2017 · Nature Genetics
  72. Cohesin Disrupts Polycomb-Dependent Chromosome Interactions in Embryonic Stem Cells
    Rhodes, James D.P., Feldmann, Angelika, Hernández-Rodríguez, Benjamín, Díaz, Noelia, Brown, Jill M., Fursova, Nadezda A., Blackledge, Neil P., Prathapan, Praveen, Dobrinic, Paula, Huseyin, Miles K. et al. · 2020 · Cell Reports
  73. Fine-scale chromatin interaction maps reveal the cis-regulatory landscape of human lincRNA genes
    Wenxiu Ma, Ferhat Ay, Choli Lee, Günhan Gülsoy, Xinxian Deng, Savannah M. Cook, Jennifer Hesson, Christopher Cavanaugh, Carol B. Ware, Anton Krumm et al. · 2014 · Nature Methods
  74. Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells
    Dyana T. Saenz, Warren C. Fiskus, Yimin Qian, Taghi Manshouri, Kimal Rajapakshe, Kanak Raina, Kevin G. Coleman, Andrew P. A. Crew, Angela Shen, Christopher Peter Mill et al. · 2017 · Leukemia
  75. Visualizing transcription factor dynamics in living cells
    Zhe J. Liu, Robert Tjian · 2018 · The Journal of Cell Biology
  76. Recent advances in the developmental origin of neuroblastoma: an overview
    Mirco Ponzoni, Tiziana Bachetti, Maria Valeria Corrias, Chiara Brignole, Fabio Pastorino, Enzo Calarco, Veronica Bensa, Elena Giusto, Isabella Ceccherini, Patrizia Perri · 2022 · Journal of Experimental & Clinical Cancer Research
  77. MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis
    Lai, Binbin, Lee, Ji-Eun, Jang, Younghoon, Wang, Lifeng, Peng, Weiqun, Ge, Kai · 2017 · Nucleic Acids Research
  78. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells
    Patrick L. Collins, Marina Cella, Sofia I. Porter, Shasha Li, Greer L. Gurewitz, Henoch Sangjoon Hong, R. Paul Johnson, Eugene M. Oltz, Marco Colonna · 2018 · Cell
  79. Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State
    Surya Nagaraja, Michael A. Quezada, Shawn M. Gillespie, Marlene Arzt, James Lennon, Pamelyn J. Woo, Volker Hovestadt, Madhuri Kambhampati, Mariella G. Filbin, Mario L. Suvà et al. · 2019 · Molecular Cell
  80. Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex
    Shen, Hongjie, Xu, Wenqi, Guo, Rui, Rong, Bowen, Gu, Lei, Wang, Zhentian, He, Chenxi, Zheng, Lijuan, Hu, Xin, Hu, Zhen et al. · 2016 · Cell
  81. CD4 T cell differentiation in type 1 diabetes
    Lucy S. K. Walker, Matthias von Herrath · 2015 · Clinical & Experimental Immunology
  82. Glioma Stem Cell–Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling
    Ryan C. Gimple, Reilly L. Kidwell, Leo J.Y. Kim, Tengqian Sun, Anthony D. Gromovsky, Qiulian Wu, Megan E Wolf, Deguan Lv, Shruti Bhargava, Li Jiang et al. · 2019 · Cancer Discovery
  83. Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
    Paloma Cejas, Yotam Drier, Koen M.A. Dreijerink, Lodewijk A.A. Brosens, Vikram Deshpande, Charles B. Epstein, Elfi B. Conemans, Folkert H.M. Morsink, Mindy Kim Graham, Gerlof Dirk Valk et al. · 2019 · Nature Medicine
  84. Targeting Cancer Cells with BET Bromodomain Inhibitors
    Yali Xu, Christopher R. Vakoc · 2017 · Cold Spring Harbor Perspectives in Medicine
  85. Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients
    Brian A. Walker, Christopher P. Wardell, Annamaria Brioli, Eileen Mary Boyle, Martin Kaiser, Dil B Begum, Nasrin B. Dahir, David C. Johnson, F. M. Ross, Faith E. Davies et al. · 2014 · Blood Cancer Journal
  86. BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells
    Baohua Sun, Warren C. Fiskus, Yimin Qian, Kimal Rajapakshe, Kanak Raina, Kevin G. Coleman, Andrew P. A. Crew, Angela Shen, Dyana T. Saenz, Christopher Peter Mill et al. · 2017 · Leukemia
  87. Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits
    Farhad Hormozdiari, Steven Gazal, Bryce van de Geijn, Hilary K. Finucane, Chelsea J.‐T. Ju, Po‐Ru Loh, Armin P. Schoech, Yakir Reshef, Xuanyao Liu, Luke Jen O’Connor et al. · 2018 · Nature Genetics
  88. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines
    Yan‐Yi Jiang, Yuan Jiang, Chun-Quan Li, Ying Zhang, Pushkar Dakle, Kaur Hp, Jian-Wen Deng, Ruby Yu‐Tong Lin, Yiwu Yan, Jian-Jun Xie et al. · 2020 · Gastroenterology
  89. Small Molecule Inhibitors of Bromodomain–Acetyl-lysine Interactions
    Michael J. D. Brand, Angelina M. Measures, Brian G. Wilson, Wilian Augusto Cortopassi, Rikki P. Alexander, Matthias Höss, David S. Hewings, Timothy P. C. Rooney, Robert S. Paton, Stuart J. Conway · 2014 · ACS Chemical Biology
  90. Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
    Jonathan S. Mitchell, Li Ni, Niels Weinhold, Asta Försti, Mina Ali, Mark van Duin, Guðmar Þorleifsson, David C. Johnson, Bowang Chen, Britt-Marie Halvarsson et al. · 2016 · Nature Communications
  91. Genome-Wide Prediction and Validation of Intergenic Enhancers in Arabidopsis Using Open Chromatin Signatures
    Bo Zhu, Wenli Zhang, Tao Zhang, Liu B, Jiming Jiang · 2015 · The Plant Cell
  92. The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations
    Francesca Menghi, Floris P Barthel, Vinod Kumar Yadav, Ming Tang, Bo Ji, Zhonghui Tang, Gregory W. Carter, Yijun Ruan, Ralph Scully, Roel G.W. Verhaak et al. · 2018 · Cancer Cell
  93. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
    GEMO Study Collaborators, Laura Fachal, EMBRACE Collaborators, KConFab Investigators, HEBON Investigators, ABCTB Investigators, Hugues Aschard, Jonathan Beesley, Daniel R. Barnes, Jamie Allen et al. · 2020 · Nature Genetics
  94. EP300 Selectively Controls the Enhancer Landscape of MYCN -Amplified Neuroblastoma
    Adam David Durbin, Tingjian Wang, Virangika K. Wimalasena, Mark W. Zimmerman, Deyao Li, Neekesh V. Dharia, Luca Mariani, Noha A.M. Shendy, Stephanie Nance, Anand G. Patel et al. · 2021 · Cancer Discovery
  95. Epstein-Barr Virus Oncoprotein Super-enhancers Control B Cell Growth
    Hufeng Zhou, Stefanie C.S. Schmidt, Sizun Jiang, Bradford Willox, Katharina Bernhardt, Jun Liang, Eric Johannsen, Peter V. Kharchenko, Benjamin E. Gewurz, Elliott D. Kieff et al. · 2015 · Cell Host & Microbe
  96. The many lives of KATs — detectors, integrators and modulators of the cellular environment
    Bilal N. Sheikh, Asifa Akhtar · 2018 · Nature Reviews Genetics
  97. Acetyl-CoA regulates lipid metabolism and histone acetylation modification in cancer
    Weijing He, Qingguo Li, Xinxiang Li · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  98. A Systematic Approach to Identify Candidate Transcription Factors that Control Cell Identity
    D’Alessio, Ana C., Fan, Zi Peng, Wert, Katherine J., Baranov, Petr, Cohen, Malkiel A., Saini, Janmeet S., Cohick, Evan, Charniga, Carol, Dadon, Daniel, Hannett, Nancy M. et al. · 2015 · Stem Cell Reports
  99. MBD3/NuRD Facilitates Induction of Pluripotency in a Context-Dependent Manner
    Rodrigo L. dos Santos, Luca Tosti, Aliaksandra Radzisheuskaya, Isabel Martín Caballero, Keisuke Kaji, Brian Hendrich, José Silva · 2014 · Cell stem cell
  100. Rewiring cancer drivers to activate apoptosis
    Sai P. Gourisankar, A. Krokhotin, Wenzhi Ji, Xiaofan Liu, Chiung-Ying Chang, Samuel H. Kim, Zhengnian Li, Wendy Wenderski, Juste Simanauskaite, Haopeng Yang et al. · 2023 · Nature